STRIDE DUO Trademark

Trademark Overview


On Thursday, September 5, 2024, a trademark application was filed for STRIDE DUO with the United States Patent and Trademark Office. The USPTO has given the STRIDE DUO trademark a serial number of 98735029. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 5, 2024. This trademark is owned by Distinct Dermatology Inc.. The STRIDE DUO trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Nail fungus treatment; Toenail fungus treatment using oral antifungal medications and topical solution; Medicated skin care treatment
stride duo

General Information


Serial Number98735029
Word MarkSTRIDE DUO
Filing DateThursday, September 5, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesNail fungus treatment; Toenail fungus treatment using oral antifungal medications and topical solution; Medicated skin care treatment

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 5, 2024
Primary Code044
First Use Anywhere DateFriday, July 19, 2024
First Use In Commerce DateFriday, July 19, 2024

Trademark Owner History


Party NameDistinct Dermatology Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParaippany, NJ 07981

Trademark Events


Event DateEvent Description
Thursday, September 5, 2024NEW APPLICATION ENTERED
Thursday, September 5, 2024APPLICATION FILING RECEIPT MAILED
Saturday, September 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED